Metabolomics Workbench : NIH Data Repository

Reversed phase POSITIVE ION MODE (Analysis AN004534)

Metabolite	Structure	F1	F2	F3	F4	F5	F6
1-Methyl-hydantoin	ME723407	0.46	0.65	2.31	0.42	1.28	1.06
1-amino-1-cyclobutane carboxylic acid	ME722631	1.16	1.20	1.05	0.89	1.00	0.53
1-Acetylindole	ME723404	1.19	1.29	0.92	0.91	0.76	0.83
2,4-Dihydroxypteridine	ME723378	1.12	1.15	0.77	0.62	1.04	1.43
1,3-Dicyclohexylurea	ME722692	0.94	0.95	1.04	1.00	1.05	1.03
(1R,6S)-6-amino-5-oxocyclohexyl-2-ene-1-carboxylic acid ester	ME723326	1.03	1.24	0.86	1.22	0.74	0.71
2,4-diacetamino-2,4,6-triphenoxy-D-mannopyranose	ME723342	0.57	0.99	0.86	1.19	1.57	0.55
2,2^-Cyclouridine	ME723127	1.21	1.39	0.69	0.89	0.50	1.35
18ß-Glycyrrhetinic acid	ME723168	1.94	1.59	0.73	0.47	0.50	0.74
2,4-Quinolinediol	ME723416	0.90	0.98	1.35	0.99	0.85	0.92
1-Hydroxylamino-2-phenylethane	ME722649	1.10	1.24	0.90	1.11	0.73	0.77
1-Methylguanine	ME723140	0.93	1.31	0.77	0.81	0.93	1.20
1-Methyladenosine	ME723143	1.06	1.47	0.69	1.10	0.81	0.58
20,26-dihydroxyecdysone	ME723156	1.45	1.52	0.83	0.90	0.61	0.44
2,2-Dihydroxymethyl-1-azabicyclo[2.2.2]octan-3-one	ME723417	1.40	1.23	0.72	1.00	0.89	0.63
1,4-Dihydro-1-Methyl-4-Oxo-3-Pyridinecarboxamide	ME723382	0.90	1.12	1.51	0.71	1.15	0.45
1-Methylguanosine	ME723119	1.16	1.07	1.03	0.72	1.08	0.97
16-Dehydroprogesterone	ME723157	1.04	1.65	1.30	0.71	0.55	0.43
1-Methylpiperidine-2-carboxylic acid	ME722627	0.70	0.56	0.97	0.74	1.14	2.43
1,7-Dimethylxanthine	ME723131	0.42	0.57	0.30	0.69	2.06	2.34
1-deoxyvaleric acid	ME723359	1.00	1.00	0.97	1.02	1.01	0.97
1-(2,4-Dihydroxyphenyl)-2-(4-hydroxyphenyl)propan-1-one	ME722671	0.25	0.04	2.61	0.99	0.67	2.09
10-Formyl-Thf	ME723397	0.84	0.85	0.29	1.15	2.20	0.38
15-keto Prostaglandin E1	ME723367	2.28	1.78	0.14	0.37	0.95	0.25

F1	Group type:Colorectal adenoma \| Sex:Female
F2	Group type:Colorectal adenoma \| Sex:Male
F3	Group type:Colorectal cancer \| Sex:Female
F4	Group type:Colorectal cancer \| Sex:Male
F5	Group type:Heathy control \| Sex:Female
F6	Group type:Heathy control \| Sex:Male

Data matrix